A targeted lipidomics approach to the study of eicosanoid release in synovial joints

Arthritis Research and Therapy

Volumn 13, Issue 4, 2011, Pages

  De Grauw, Janny C ^a   Van De Lest, Chris H A ^b   Van Weeren, Paul R ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYICOSATETRAENOIC ACID; ICOSANOID; LEUKOTRIENE B4; MELOXICAM; PROSTAGLANDIN A2; PROSTAGLANDIN E2; THROMBOXANE B2; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; DISCRIMINANT ANALYSIS; ELECTROSPRAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ICOSANOID METABOLISM; JOINT; LIPIDOMICS; LIQUID CHROMATOGRAPHY; NONHUMAN; SOLID PHASE EXTRACTION; SYNOVIAL FLUID; SYNOVITIS; TANDEM MASS SPECTROMETRY; ANIMAL; CHEMISTRY; HORSE; METABOLISM; METHODOLOGY; SECRETION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EICOSANOIDS; HORSES; SYNOVIAL FLUID; SYNOVITIS; TANDEM MASS SPECTROMETRY;

EID: 79960659221     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3427     Document Type: Article

References (34)

1. Crofford LJ. COX-2 in synovial tissues. Osteoarthritis Cartilage 1999, 7:406-408. 10.1053/joca.1999.0226, 10419782.
2. McCoy JM, Wicks JR, Audoly LP. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 2002, 110:651-658. 151107, 12208866.
3. Martel-Pelletier J, Pelletier JP, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 2003, 33:155-167. 10.1016/S0049-0172(03)00134-3, 14671726.
4. Molloy ES, McCarthy GM. Eicosanoids, osteoarthritis, and crystal deposition diseases. Curr Opin Rheumatol 2005, 17:346-350. 10.1097/01.bor.0000155363.61120.c3, 15838249.
5. Yacoubian S, Serhan CN. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Nat Clin Pract Rheumatol 2007, 3:570-579. 10.1038/ncprheum0616, 17906612.
6. Sato T, Konomi K, Fujii R, Aono H, Aratani S, Yagishita N, Araya N, Yudoh K, Beppu M, Yamano Y, Nishioka K, Nakajima T. Prostaglandin EP2 receptor signalling inhibits the expression of matrix metalloproteinase 13 in human osteoarthritic chondrocytes. Ann Rheum Dis 2011, 70:221-226. 10.1136/ard.2009.118620, 20870807.
7. Tchetina EV, Di Battista JA, Zukor DJ, Antoniou J, Poole AR. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy. Arthritis Res Ther 2007, 9:R75. 10.1186/ar2273, 2206385, 17683641.
8. Bertin P, Lapicque F, Payan E, Rigaud M, Bailleul F, Jaeger S, Treves R, Netter P. Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid. Eur J Clin Pharmacol 1994, 46:3-7.
9. de Grauw JC, van de Lest CH, Brama PA, Rambags BP, van Weeren PR. In vivo effects of meloxicam on inflammatory mediators, MMP activity and cartilage biomarkers in equine joints with acute synovitis. Equine Vet J 2009, 41:693-699. 10.2746/042516409X436286, 19927589.
10. Mastbergen SC, Marijnissen AC, Vianen ME, Zoer B, van Roermund PM, Bijlsma JW, Lafeber FP. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis. Rheumatology (Oxford) 2006, 45:405-413.
11. Il'yasova D, Morrow JD, Ivanova A, Wagenknecht LE. Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane. Ann Epidemiol 2004, 14:793-797. 10.1016/j.annepidem.2004.03.003, 15519902.
12. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 2006, 78:779-787. 10.1021/ac051437y, 16448051.
13. R development Core team R: A Language and Environment for Statistical Computing. 2011, Vienna, Austria: R Foundation for Statistical Computing, ISBN 3-900051-07-0, R development Core team., http://www.R-project.org
14. Pollard KS, Dudoit S, van der Laan MJ. Multiple testing procedures: the multtest package and applications to genomics. Bioinformatics and Computational Biology Solutions Using R and Bioconductor 2005, 251-272. New York: Springer, Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S.
15. Masoodi M, Mir AA, Petasis NA, Serhan CN, Nicolaou A. Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun Mass Spectrom 2008, 22:75-83. 10.1002/rcm.3331, 2542421, 18059001.
16. Margalit A, Duffin KL, Isakson PC. Rapid quantitation of a large scope of eicosanoids in two models of inflammation: development of an electrospray and tandem mass spectrometry method and application to biological studies. Anal Biochem 1996, 235:73-81. 10.1006/abio.1996.0093, 8850549.
17. Takabatake M, Hishinuma T, Suzuki N, Chiba S, Tsukamoto H, Nakamura H, Saga T, Tomioka Y, Kurose A, Sawai T, Mizugaki M. Simultaneous quantification of prostaglandins in human synovial cell-cultured medium using liquid chromatography/tandem mass spectrometry. Prostaglandins Leukot Essent Fatty Acids 2002, 67:51-56. 10.1054/plef.2002.0381, 12213436.
18. Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M, FitzGerald GA. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Invest 2003, 112:945-955. 193665, 12975479.
19. van den Boom R, van de Lest CH, Bull S, Brama RA, van Weeren PR, Barneveld A. Influence of repeated arthrocentesis and exercise on synovial fluid concentrations of nitric oxide, prostaglandin E2 and glycosaminoglycans in healthy equine joints. Equine Vet J 2005, 37:250-256.
20. Murphy RC, Barkley RM, Zemski Berry K, Hankin J, Harrison K, Johnson C, Krank J, McAnoy A, Uhlson C, Zarini S. Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal Biochem 2005, 346:1-42. 10.1016/j.ab.2005.04.042, 15961057.
21. Masoodi M, Nicolaou A. Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom 2006, 20:3023-3029. 10.1002/rcm.2697, 1805459, 16986207.
22. Gijon MA, Zarini S, Murphy RC. Biosynthesis of eicosanoids and transcellular metabolism of leukotrienes in murine bone marrow cells. J Lipid Res 2007, 48:716-725.
23. Cao H, Xiao L, Park G, Wang X, Azim AC, Christman JW, van Breemen RB. An improved LC-MS/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluids. Anal Biochem 2008, 372:41-51. 10.1016/j.ab.2007.08.041, 2276632, 17976507.
24. Maskrey BH, O'Donnell VB. Analysis of eicosanoids and related lipid mediators using mass spectrometry. Biochem Soc Trans 2008, 36:1055-1059. 10.1042/BST0361055, 18793188.
25. Surette ME, Odeimat A, Palmantier R, Marleau S, Poubelle PE, Borgeat P. Reverse-phase high-performance liquid chromatography analysis of arachidonic acid metabolites in plasma after stimulation of whole blood ex vivo. Anal Biochem 1994, 216:392-400. 10.1006/abio.1994.1057, 8179194.
26. Wittenberg RH, Willburger RE, Kleemeyer KS, Peskar BA. In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum 1993, 36:1444-1450. 10.1002/art.1780361017, 8216404.
27. Amin A, Attur M, Dave M, Leung M, Serhan C, Abramson S. Functional and pharmacogenomic analysis of lipid mediators in human osteoarthritis-affected cartilage [abstract]. Arthritis Rheum 2002, 46:S221.
28. Abramson SB. Inflammation in osteoarthritis. J Rheumatol Suppl 2004, 70:70-76.
29. Scher JU, Pillinger MH. The anti-inflammatory effects of prostaglandins. J Investig Med 2009, 57:703-708.
30. Pulichino AM, Rowland S, Wu T, Clark P, Xu D, Mathieu MC, Riendeau D, Audoly LP. Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis. J Pharmacol Exp Ther 2006, 319:1043-1050. 10.1124/jpet.106.110387, 16973887.
31. Norris PC, Reichart D, Dumlao DS, Glass CK, Dennis EA. Specificity of eicosanoid production depends on the TLR-4-stimulated macrophage phenotype. J Leukoc Biol 2011,
32. Marcouiller P, Pelletier JP, Guevremont M, Martel-Pelletier J, Ranger P, Laufer S, Reboul P. Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis. J Rheumatol 2005, 32:704-712.
33. Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, Lee DM. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med 2006, 203:837-842. 10.1084/jem.20052371, 2118292, 16567388.
34. Zhai B, Yang H, Mancini A, He Q, Antoniou J, Di Battista JA. Leukotriene B(4) BLT receptor signaling regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of Ras/Raf/ERK/p42 AUF1 pathway. J Biol Chem 2010, 285:23568-23580. 10.1074/jbc.M110.107623, 2911275, 20489206.